{"id":528871,"date":"2021-02-04T16:10:02","date_gmt":"2021-02-04T16:10:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=528871"},"modified":"2021-02-04T16:10:02","modified_gmt":"2021-02-04T16:10:02","slug":"nicotine-addiction-market-analysis-leading-companies-emerging-drugs-and-epidemiology-forecast","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/nicotine-addiction-market-analysis-leading-companies-emerging-drugs-and-epidemiology-forecast_528871.html","title":{"rendered":"Nicotine Addiction Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast"},"content":{"rendered":"
\"Nicotine<\/a><\/p>\n
\n
Delveinsight Business Research LLP<\/p>\n<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Nicotine Addiction Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Nicotine Addiction, historical and forecasted epidemiology as well as the Nicotine Addiction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n

Nicotine<\/strong> is an addictive substance found in all tobacco products. In addition to being addictive, it is poisonous. Nicotine is a tertiary amine composed of pyridine and a pyrrolidine ring. It is metabolized primarily by the enzyme CYP2A6, and variation in the rate of nicotine metabolism contributes to differences in vulnerability to tobacco dependence and the response to smoking-cessation treatment. Low doses of nicotine can act as a central nervous system stimulant.<\/p>\n

Nicotine<\/strong> can be expected to remain in the blood at significant levels for six to eight hours after the smoking stopped. Regular use of nicotine-containing products will result in physical withdrawal symptoms resembling amphetamine and cocaine dependency. It causes erectile dysfunction (males), heart disease, lung disease, chronic obstructive pulmonary disease (COPD), and certain eye disease. Nicotine addiction has a male predominance<\/strong>. Globally, about 40% of men smoke as compared with nearly 9% of women.<\/p>\n

Get FREE sample copy at: <\/strong>
https:\/\/www.delveinsight.com\/sample-request\/nicotine-addiction-market<\/strong><\/a><\/p>\n

The Nicotine Addiction market report<\/strong> also covers emerging drugs, current treatment practices, Nicotine Addiction market share of the individual therapies, current and forecasted Nicotine Addiction Market Size from 2017 to 2030 segmented by seven major markets. <\/p>\n

The report provides a detailed current Nicotine Addiction treatment practice<\/strong>\/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. <\/p>\n

 <\/p>\n

 <\/p>\n

\"Nicotine<\/p>\n

 <\/p>\n

Nicotine Addiction Market Key Facts
<\/strong>As per the CDC, ‘Cigarette smoking is responsible for more than 480,000 deaths per year in the United States<\/strong>, including more than 41,000 deaths resulting from secondhand smoke exposure. This is about one in five deaths annually, or 1,300 deaths every day’.<\/p>\n

Worldwide, tobacco use causes nearly 6 million deaths per year, and current trends show that tobacco use will cause more than 8 million deaths annually by 2030.<\/p>\n

In 2016, the prevalence of current cigarette smoking<\/strong> among adults was 15.5%, which was a significant decline from 2005 (20.9%); however, no significant change has occurred since 2015 (15.1%)<\/p>\n

According to WHO, “Of the more than 5 million people who die every year from tobacco use, approximately 1.5 million are women”. Unless urgent action is taken, tobacco use could kill up to 8 million people every year by 2030, of which 2.5 million would be women.<\/p>\n

Key Benefits of Nicotine Addiction Market Report<\/strong><\/p>\n